Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the anti-microbial peptide LL37 has been shown to promote trafficking of aggregated DNA structures to the early endosome, promoting TLR9 activation and interferon production (Lande et al., 2007)”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Lande et al., 2007
In the citing paper
“Interestingly, suction blister wounds, where the blister roof is still intact, do not show substantial inflammation,9 whereas excisional wounds, ultraviolet (UV)-induced skin damage, superficial tape stripping or chemical skin irritants, and contact sensitizers cause inflammatory infiltrates,17,23–26”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [23]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citation
Cited by
Items 601–700 of 1,000
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
Holm, S., Kared, H., Michelsen, A. E., Kong, X. Y., Dahl, T. B., Schultz, N. H., Nyman, T. A., Fladeby, C., Seljeflot, I., Ueland, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab506 · Cited by 62
Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
Barbieux, C., Claustres, M. B. D., Fahrner, M., Petrova, E., Tsoi, L. C., Gouin, O., Leturcq, F., Nicaise‐Roland, P., Bôle‐Feysot, C., Béziat, V., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.08.024 · Cited by 67
An Update on the Role of Adipose Tissues in Psoriasis
Wong, Y., Nakamizo, S., Tan, K. J., & Kabashima, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01507 · Cited by 66
“They form complexes with human self-DNA and in turn activate dermal plasmacytoid dendritic cells via toll-like receptor 9 (TLR9) to produce interferon-α (IFN-α) to stimulate T-cellmediated immune responses (30).”
BackgroundWakkee, M., & Nijsten, T. E. C. (2009) · Dermatologic Clinics · doi:10.1016/j.det.2008.11.013 · Cited by 67
“These results may be related to the increased expression of antimicrobial peptides and proteins (AMPs) in psoriatic skin.(45,46) AMPs are involved in the innate defense against bacterial infections and clinical expression of these natural antibiotics correlate with the susceptibility to skin infections.”
BackgroundRies, M., Schuster, P., Thomann, S., Donhauser, N., Vollmer, J., & Schmidt, B. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0612278 · Cited by 61
“LL-37 contributes to the uptake of cellular DNA into early endosomes of PDC in psoriatic skin lesions [52].”
BackgroundVarious Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation
Ramadan, A. M., & Paczesny, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00014 · Cited by 72
Chiang, E. Y., Yu, X., & Grogan, J. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002821 · Cited by 61
“Self-DNA capable of activating TLR9 signaling may also occur in the absence of IC formation, as seen in psoriasis where DNA uptake by pDCs is facilitated by the antimicrobial peptide LL37 (51).”
BackgroundDeenonpoe, R., Prayong, P., Thippamom, N., Meephansan, J., & Na‐Bangchang, K. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2535-3 · Cited by 65
“The complexes activate plasmacytoid dendritic cells (pDCs) to produce type I interferons (IFNs), which in turn, activate myeloid DCs (mDCs) through Toll-like receptor 8 (TLR8) [6].”
BackgroundAutoimmune aspects of psoriasis: Heritability and autoantigens
Prinz, J. C. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.011 · Cited by 71
“DNA sensing by plasmacytoid dendritic cells through LL37 and endosomal Toll-like receptors is a potent trigger of interferon production in psoriasis [143].”
BackgroundLiu, X., Chen, S., Huang, J., Du, Y., Luo, Z., Zhang, Y., Liu, L., & Chen, Y. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01759-2 · Cited by 70
Curtis, B. J., & Radek, K. A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.264 · Cited by 65
Ward, C. L., Sánchez, C. J., Pollot, B. E., Romano, D. R., Hardy, S. K., Becerra, S. C., Rathbone, C. R., & Wenke, J. C. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0412-x · Cited by 69
“Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.”
BackgroundInfluentialExpression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions
Kopfnagel, V., Harder, J., & Werfel, T. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328364ddfd · Cited by 60
Ma, L., Wang, Y., Wang, M., Tian, Y., Kang, W. C. M., Liu, H., Wang, H., Dou, J., & Zhou, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.011 · Cited by 60
Self-citationDevos, M., Mogilenko, D. A., Fleury, S., Gilbert, B., Becquart, C., Quemener, S., Dehondt, H., Tougaard, P., Staels, B., Bachert, C., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.191 · Cited by 67
Martins, A. M., Ascenso, A., Ribeiro, H. M., & Marto, J. M. (2020) · Cells · doi:10.3390/cells9040796 · Cited by 79
“Keratinocytes are also able to activate mDCs to produce IL-1β and IL-6 via IL-36 cytokines [109], and activate macrophages via overexpressed LL37, further promoting inflammation [85].”
BackgroundInfluentialProtecting the boundary: the sentinel role of host defense peptides in the skin
Bernard, J. J., & Gallo, R. L. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0712-8 · Cited by 67
“complexed with LL-37, activates plasmacytoid dendritic cells (pDCs) through TLR9 [ 96 ].”
BackgroundThe emerging role of neutrophils in neurodegeneration
Rossi, B., Constantin, G., & Zenaro, E. (2019) · Immunobiology · doi:10.1016/j.imbio.2019.10.014 · Cited by 62
Charles, J., Chaperot, L., Salameire, D., Domizio, J. D., Aspord, C., Gressin, R., Jacob, M., Richard, M., Béani, J., Plumas, J., et al. (2010) · European Journal of Dermatology · doi:10.1684/ejd.2010.0816 · Cited by 60
“These complexes are delivered to the early endocytic compartment of PDC to trigger TLR9 and thereby IFN-α production (22).”
BackgroundYi, Y., Zhou, Z.-X., Shu, S., Fang, Y., Twitty, C., Hilton, T. L., Aung, S., Urba, W. J., Fox, B. A., Hu, H., et al. (2012) · OncoImmunology · doi:10.4161/onci.20059 · Cited by 63
“In addition to the CLEC9A ligand, other potential DAMP molecules include cellular DNA and RNA, possibly in complexes with bactericidal peptide LL-37 (cathelicidin), HSPs and calreticulin.(6,7) Oppenheim first coined the term alarmins to describe one Figure 1.”
BackgroundGuimarães-Costa, A. B., Rochael, N. C., Oliveira, F., Echevarria‐Lima, J., & Saraiva, E. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00523 · Cited by 64
“NETs were previously shown to be the major inducer of type I IFN production by plasmacytoid DCs during autoimmune disease (5), a possible explanation for NETs’ downregulation of the IL-4R would be through the production of IFN by NETs-treated monocytes.”
BackgroundInnate immunity in systemic lupus erythematosus: Sensing endogenous nucleic acids
Kontaki, E., & Boumpas, D. T. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.06.009 · Cited by 64
Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid
Balato, A., Schiattarella, M., Lembo, S., Mattii, M., Prevete, N., Balato, N., & Ayala, F. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1327-8 · Cited by 61
“In ex vivo healthy skin organ culture, TNF-a and IL-17 were able to increase almost all IL-1 family members, being IL-17 a significant more potent inducer of all cytokines, confirming the axis TNF-a, IL-17 and IL-1 family in skin inflammation [6, 7, 12, 14, 19, 25].”
BackgroundRNase 7 Strongly Promotes TLR9-Mediated DNA Sensing by Human Plasmacytoid Dendritic Cells
Kopfnagel, V., Wagenknecht, S., Harder, J., Hofmann, K., Kleine, M., Buch, A., Sodeik, B., & Werfel, T. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.09.052 · Cited by 68
“Lande et al. (2007) identified LL-37 as a key factor that mediates pDC activation by self-DNA in psoriasis (Lande et al., 2007).”
BackgroundInfluentialMechanisms and disease relevance of neutrophil extracellular trap formation
Avondt, K. V., & Hartl, D. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12919 · Cited by 62
“Self-DNA coupled with the antimicrobial peptide LL-37 was found to activate pDCs to release type I IFNs.(81) Circulating serum endonuclease DNase I is believed to be essential for the disaggregation/cleavage of DNA-NETs.”
BackgroundThe Antimicrobial and Immunomodulatory Function of RNase 7 in Skin
Rademacher, F., Dreyer, S., Kopfnagel, V., Gläser, R., Werfel, T., & Harder, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02553 · Cited by 58
Zhang, L., Guerrero‐Juarez, C. F., Chen, S., Zhang, X., Yin, M., Li, F., Wu, S., Chen, J., Li, M., Liu, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5280 · Cited by 65
Self-citationImmune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy
Speeckaert, R., van Geel, N., Vermaelen, K., Lambert, J., Gele, M. V., Speeckaert, M. M., & Brochez, L. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00799.x · Cited by 64
“This mechanism is thought to underly the pathological pDCdependent auto-immune activation of T cells within psoriatic lesions (Lande et al., 2007).”
BackgroundHeat-Shock Proteins as Endogenous Ligands Building a Bridge Between Innate and Adaptive Immunity
Tamura, Y., Torigoe, T., Kukita, K., Saito, K., Okuya, K., Kutomi, G., Hirata, K., & Sato, N. (2012) · Immunotherapy · doi:10.2217/imt.12.75 · Cited by 57
Chemokines in the Pathogenesis of Lichenoid Tissue Reactions
Meller, S., Gilliet, M. F., & Homey, B. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.251 · Cited by 56
Self-citationAnti-cytokine therapies for psoriasis
Nograles, K. E., & Krueger, J. G. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.024 · Cited by 66
Di Domizio, J., Dorta-Estremera, S., Gagea, M., Ganguly, D., Meller, S., Li, P., Zhao, B., Tan, F. K., Bi, L., Gilliet, M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206923109 · Cited by 57
“, type A CpG oligonucleotide and LL-37 complexed with nucleic acids (22, 26).”
BackgroundSelf-citationThe Coordinated Response of the Physical and Antimicrobial Peptide Barriers of the Skin
Borkowski, A. W., & Gallo, R. L. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.360 · Cited by 61
“In psoriasis, AMPs, including LL37, hBD-2, and hBD-3, are all upregulated and are believed to contribute to inflammation and to the pathogenesis of the disease (Gilliet and Lande, 2008; Lande et al., 2007).”
BackgroundChiliveru, S., Rahbek, S. H., Jensen, S. K., Jørgensen, S. E., Nissen, S. K., Christiansen, S. H., Mogensen, T. H., Jakobsen, M. R., Iversen, L., Johansen, C., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302120 · Cited by 59
“LL37 couples with DNA and converts it into a potent DAMP, a trigger of type I IFN in pDCs (5).”
BackgroundInfluentialIL-27 Facilitates Skin Wound Healing through Induction of Epidermal Proliferation and Host Defense
Yang, B., Suwanpradid, J., Lagunes, R. S., Choi, H. W., Hoang, P., Wang, D., Abraham, S. N., & MacLeod, A. S. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.01.010 · Cited by 59
“Following skin injury, nucleic acids, specifically doublestranded RNA, and other danger signals are released from damaged cells and trigger potent immune responses (Bernard et al., 2012; Gregorio et al., 2010; Lande et al., 2007; MacLeod et al., 2014; Nelson et al., 2015).”
BackgroundGarzorz‐Stark, N., Lauffer, F., Krause, L., Thomas, J., Atenhan, A., Franz, R., Roenneberg, S., Boehner, A., Jargosch, M., Batra, R., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.045 · Cited by 57
“Antimicrobial peptides, chemokines, and complexes of self-DNA or microbial DNA orchestrate the stimulation of pDCs to secrete IFN-a and a subsequent TH17 immune response.(2,30,31) Our study confirms that the number of TLR7(1) pDCs increases on stimulation with imiquimod.”
BackgroundMouse models of psoriasis and their relevance
Nakajima, K., & Sano, S. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14112 · Cited by 63
Dendritic cells and cytokines in immune rejection of cancer
Ferrantini, M., Capone, I., & Belardelli, F. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.10.003 · Cited by 59
“These findings, together with the increasing evidence of the role of pDCs and type IFNs in the pathogenesis of autoimmune diseases in humans [120,121], put forward the challenging hypothesis of pDC involvement in the IFN-induced immune responses leading to antitumor immunity and associated autoimmunity.”
Toll-like receptors in mediating pathogenesis in systemic sclerosis
Frasca, L., & Lande, R. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13426 · Cited by 61
Self-citationOrchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action
Noor, A. A. M., Azlan, M., & Redzwan, N. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020498 · Cited by 66
Farkas, Á., & Kemény, L. V. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10301.x · Cited by 56
dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity
Wang, Y., Swiecki, M. K., McCartney, S. A., & Colonna, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01049.x · Cited by 67
“LL37 converts inert self-DNA into aggregated, condensed structures that are delivered to and retained within early TLR9 endocytic compartments, where they trigger IFN-I production by pDCs (187).”
BackgroundSelf-citationImpact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression
Antal, A. S., Dombrowski, Y., Koglin, S., Ruzicka, T., & Schauber, J. (2011) · Dermato-Endocrinology · doi:10.4161/derm.3.1.14616 · Cited by 61
“Consecutively, secreted IFN-γ activates a T-cell response that leads to cutaneous inflammation.(70) The self-DNA needed for the initiation of this inflammatory cascade might come from dead and dying cells in the psoriatic plaque.”
BackgroundInfluentialDNase 2 Is the Main DNA-Degrading Enzyme of the Stratum Corneum
Fischer, H., Scherz, J., Szabo, S., Mildner, M., Benarafa, C., Torriglia, A., Tschachler, E., & Eckhart, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017581 · Cited by 56
“Furthermore, epidermal DNase 2 may suppress inflammatory reactions by degrading extracellular DNA which, in conjunction with cathelicidin, has the potential to activate dendritic cells [8].”
BackgroundGowda, K., Wu, X., & Gowda, D. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020398 · Cited by 56
“However, complex formation with highly positively charged polypeptides leads to the formation of condensed structure, which is internalized by DCs, thereby presenting DNA to TLR9 in the endosomal compartment [48].”
BackgroundClinic and pathophysiology of photosensitivity in lupus erythematosus
Lehmann, P., & Homey, B. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.12.012 · Cited by 56
“Among memory T cell subsets, CXCR3 is predominantly expressed on the surface of IFN-γ-producing TH1 cells.”
BackgroundInfluentialSelf-citationThe Roles of Lipoprotein in Psoriasis
Shih, C., Chen, C.-C., Chu, C.-K., Wang, K.-H., Huang, C., & Lee, A.-W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030859 · Cited by 69
“In psoriasis lesions, the increase in CAMP production initiates pathogenic interferon (IFN) signaling cascades and the activation of DCs, resulting in uncontrolled inflammatory reactions [25].”
BackgroundA Dual Role of Type I Interferons in Antitumor Immunity
Zhou, L., Zhang, Y., Wang, Y., Zhang, M., Sun, W., Dai, T., Wang, A., Wu, X., Zhang, S., Wang, S., et al. (2020) · Advanced Biosystems · doi:10.1002/adbi.201900237 · Cited by 64
Self-citationNeutrophil Extracellular Traps in Airway Diseases: Pathological Roles and Therapeutic Implications
Jo, A., & Kim, D. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24055034 · Cited by 64
“Increased levels of LL-37 have been reported in severe disease and exacerbations [49,50].”
BackgroundYu, W., Guo, X., Li, Q., Li, X., Wei, Y., Shao, C., Zhang, L., Wang, J., & Shan, A. (2024) · Advanced Fiber Materials · doi:10.1007/s42765-024-00410-y · Cited by 56
Antimicrobial Proteins in Intestine and Inflammatory Bowel Diseases
Kim, J. M. (2014) · Intestinal Research · doi:10.5217/ir.2014.12.1.20 · Cited by 68
“Cathelicidins influence TLR signaling by affecting the internalization of TLR ligands or changing cell surface membrane microdomain function.(120,121) The human cathelicidin LL-37 increases the production of type I interferon by activating TLR-9 through the interaction with DNA.”
BackgroundTakiguchi, T., Morizane, S., Yamamoto, T., Kajita, A., Ikeda, K., & Iwatsuki, K. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12942 · Cited by 58
Nijnik, A., Pistolic, J., Filewod, N. C. J., & Hancock, R. E. W. (2012) · Journal of Innate Immunity · doi:10.1159/000335901 · Cited by 64
The Translocation of Nuclear Molecules During Inflammation and Cell Death
Pisetsky, D. S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5143 · Cited by 55
“These agents include anti-DNA antibodies; transfection agents such as lipofectin; and proteins as such as LL37 and HMGB1 (14, 28, 37, 38, 54, 57).”
IFN-α Is Constitutively Expressed in the Human Thymus, but Not in Peripheral Lymphoid Organs
Colantonio, A. D., Epeldegui, M., Jesiak, M., Jachimowski, L. C. M., Blom, B., & Uíttenbogaart, C. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024252 · Cited by 54
“In this case, the TLR-7/9 stimulus is eukaryotic nucleic acids, RNA or DNA, in complex with an anti-microbial peptide (LL-37) derived from the CAMP gene [29,30].”
BackgroundInfluentialInnate Antiviral Immunity in the Skin
Handfield, C., Kwock, J. T., & MacLeod, A. S. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.02.003 · Cited by 57
A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus
Li, Q., Wu, H., Liao, W., Zhao, M., Chan, V. S. F., Li, L., Zheng, M., Chen, G., Zhang, J., Lau, C.-S., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.007 · Cited by 57
Liang, X., Ou, C., Zhuang, J., Li, J., Zhang, F., Zhong, Y., & Chen, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.764384 · Cited by 56
“NETs activate pDC accumulation to sense microbial DNA via TLR9 and TLR7 signaling, thus promoting type I IFN expression andmay constitute a fundamental trigger of autoimmune pathology (77); in this process, LL-37 also potentiates TLR9 activation (78).”
BackgroundAloul, K. M., Nielsen, J. E., Defensor, E. B., Lin, J. S., Fortkort, J. A., Shamloo, M., Cirillo, J. D., Gombart, A. F., & Barron, A. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880961 · Cited by 56
“LL-37 facilitates the in-vitro endocytosis of extDNA by dendritic cells through a process of DNA aggregation and condensation (76).”
BackgroundHirai, T., Kanda, T., Sato, K., Takaishi, M., Nakajima, K., Yamamoto, M., Kamijima, R., DiGiovanni, J., & Sano, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200901 · Cited by 60
“It has been demonstrated that stimulation of TLR9 by complexes of the antimicrobial peptide LL37 and self-DNA results in the activation of plasmacytoid DCs (pDCs), which initiate the onset of psoriasis (6).”
BackgroundInfluentialTristetraprolin expression by keratinocytes controls local and systemic inflammation
Andrianne, M., Assabban, A., La, C., Mogilenko, D. A., Staumont-Sallé, D., Fleury, S., Doumont, G., Simaeys, G. V., Nedospasov, S. A., Blackshear, P. J., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92979 · Cited by 54
“Release of cytokines and danger signals, such as nucleic acids, by stressed or dying keratinocytes could be important initiating factors (4).”
BackgroundIL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis
Goldstein, J. D., Bassoy, E. Y., Caruso, A., Palomo, J., Rodriguez, E., Lemeille, S., & Gabay, C. (2020) · Life Science Alliance · doi:10.26508/lsa.202000688 · Cited by 61
“The antimicrobial peptide LL37, which induces type I IFN production in pDCs (Nestle et al, 2005; Lande et al, 2007; Kahlenberg & Kaplan, 2013), and Staphylococcus aureus epidermal colonization, which has been suggested to trigger psoriasis development via induction of Th17 cells (Chang et al,…”
BackgroundImaging of plasmacytoid dendritic cell interactions with T cells
Mittelbrunn, M., del Hoyo, G. M., López‐Bravo, M., Martin-Cofreces, N. B., Scholer, A., Hugues, S., Fetler, L., Amigorena, S., Ardavı́n, C., & Sánchez‐Madrid, F. (2008) · Blood · doi:10.1182/blood-2008-02-139865 · Cited by 54
Dissecting the Immune Cell Mayhem That Drives Lupus Pathogenesis
Craft, J. E. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002138 · Cited by 53
“(4) show that NETs in SLE contain LL37, a prominent DNA-binding antimicrobial peptide that facilitates NETmediated pathogen killing and, in autoimmunity, enables self-DNA and -RNA to engage TLR9 and TLR7, respectively, in pDCs, with subsequent enhancement of IFN-α release (29, 30).”
BackgroundPlasmacytoid dendritic cells in antiviral immunity and autoimmunity
Tang, F., Du, Q., & Liu, Y. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0045-0 · Cited by 61
Self-citationDyring‐Andersen, B., Bonefeld, C. M., Bzorek, M., Løvendorf, M. B., Lauritsen, J. P. H., Skov, L., & Geisler, C. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12304 · Cited by 55
Prete, F., Catucci, M., Labrada, M., Gobessi, S., Castiello, M. C., Bonomi, E., Aiuti, A., Vermi, W., Cancrini, C., Metìn, A., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20120363 · Cited by 61
“Indeed, recent studies illustrated the role of actin during clathrin-mediated endocytosis (the pathway used by CpG-A to enter cells; Latz et al., 2004).”
Boor, P. P. C., de Ruiter, P. E., Asmawidjaja, P. S., Lubberts, E., van der Laan, L. J. W., & Kwekkeboom, J. (2016) · Translational research · doi:10.1016/j.trsl.2016.11.006 · Cited by 56
Zhou, C., Yuan, Y. H., Zhou, P., Wang, F., Hong, Y., Wang, N., Xu, S., & Du, J. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01209 · Cited by 53
The Origin of Skin Dendritic Cell Network and Its Role in Psoriasis
Kim, T., Kim, S. H., & Lee, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010042 · Cited by 58
“Self-DNA released by damaged skin and antimicrobial peptide LL-37 could form self-DNA-LL-37 complex, which directly activated pDCs to produce type I interferon to promote functional maturation of myeloid DCs in psoriasis [87,88].”
BackgroundAntimicrobial Peptides in Gut Health: A Review
Gong, T., Fu, J., Shi, L., Chen, X., & Zong, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.751010 · Cited by 57
“For example, LL-37, formed a complex with DNA of host cell, activates plasma celllike DC cells through the TLR-9 signaling pathway, making IFNγ produced and autoimmune T cells activated (47, 48).”
BackgroundMechanisms regulating neutrophil responses in immunity, allergy, and autoimmunity
Özcan, A., & Boyman, O. (2022) · Allergy · doi:10.1111/all.15505 · Cited by 54
Nakatsuji, T., Brinton, S. L., Cavagnero, K. J., O’Neill, A. M., Chen, Y., Dokoshi, T., Butcher, A. M., Osuoji, O. C., Shafiq, F., Espinoza, J. L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112494 · Cited by 57
Induction of Regulatory T Cells by a Murine β-Defensin
Navid, F., Boniotto, M., Walker, C., Ahrens, K., Proksch, E., Sparwasser, T. D., Müller, W., Schwarz, T., & Schwarz, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100452 · Cited by 54
Enevold, C., Nielsen, C. H., Jacobsen, R. S., Hermansen, M. L. F., Molbo, D., Avlund, K., Bendtzen, K., & Jacobsen, S. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3447-4 · Cited by 52
“A role of TLR8 in SLE pathogenesis has not been clearly defined, but plasmacytoid dendritic cells are activated by co-stimulation through TLR7 and TLR8 by selfRNA [22, 23].”
Intracellular DNA sensors in immunity
Takeshita, F., & Ishii, K. J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.009 · Cited by 58
The role of natural antimicrobial peptides during infection and chronic inflammation
Xia, X., Cheng, L., Zhang, S., Wang, L., & Hu, J. (2017) · Antonie van Leeuwenhoek · doi:10.1007/s10482-017-0929-0 · Cited by 60
Αραμπατζιόγλου, Α., Papazoglou, D., Konstantinidis, T. G., Chrysanthopoulou, A., Mitsios, A., Angelidou, I., Maroulakou, I. G., Ritis, K., & Skendros, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02064 · Cited by 59
“LL-37-DNA complexes have been implicated in the pathogenesis of autoimmune and chronic inflammatory diseases including psoriasis (24), systemic lupus erythematosus (7), and atherosclerosis (25).”
BackgroundChemerin and the recruitment of NK cells to diseased skin.
Skrzeczyńska-Moncznik, J., Stefańska, A., Zabel, B. A., Kapińska-Mrowiecka, M., Butcher, E. C., & Cichy, J. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2468 · Cited by 49
Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application
Ariza, M. E., Williams, M. V., & Wong, H. K. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.12.004 · Cited by 55
Hu, W., Lee, S. M. L., Bazhin, A. V., Guba, M. O., Werner, J., & Nieß, H. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04310-9 · Cited by 61
Keratinocytes: new perspectives in inflammatory skin diseases
Ye, J., & Lai, Y. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.03.012 · Cited by 64
The pathophysiological role of dendritic cell subsets in psoriasis
Kim, T., Kim, D. S., Kim, H., & Lee, M. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.014 · Cited by 64
“developing psoriasis, and precedes the characteristic psoriatic phenotype (79-81).”
BackgroundMolecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy
Rácz, E., & Prens, E. P. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900129x · Cited by 52
Shibata, T., Motoi, Y., Tanimura, N., Yamakawa, N., Akashi‐Takamura, S., & Miyake, K. (2011) · International Immunology · doi:10.1093/intimm/dxr044 · Cited by 51
Stoffel, E., Maier, H., Riedl, E., Brüggen, M., Reininger, B., Schaschinger, M., Bangert, C., Guenova, E., Stingl, G., & Brunner, P. M. (2017) · British Journal of Dermatology · doi:10.1111/bjd.16126 · Cited by 51
Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects
Soni, C., & Reizis, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01601 · Cited by 58
“The pathogenic effects of NETs in psoriasis (75) and SLE (76, 77) have been attributed to their stimulatory activity on pDCs, wherein nucleic acid-mediated TLR9/7 stimulation causes type I IFN secretion, which in turn potentiates the autoinflammatory loop (76–78).”
BackgroundSandoval-Talamantes, A. K., Gómez-González, B. A., Uriarte-Mayorga, D. F., Martinez-Guzman, M. A., Hidalgo, K. A. W., & Alvarado‐Navarro, A. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.102004 · Cited by 59
Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis
Tseng, J., Chang, Y.-C., Huang, C., Hsu, L.-C., & Chuang, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071064 · Cited by 56
“LL-37, shown to function as a self-antigen, facilitates DC activations mediated by TLRs 7, 8, and 9 [49,50,85,95].”
BackgroundcGAMP the travelling messenger
Blest, H. T. W., & Chauveau, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1150705 · Cited by 59
“Additionally, LL-37 can form a complex with extracellular dsDNA able to activate endosomal TLR9 in pDCs and drive STING activation through cytoplasmic DNA sensors in monocytes (96, 97).”
BackgroundOh, S. H., Roh, H.-S., Kwon, J. E., Lee, S. H., Kim, J. Y., Choi, H. J., & Lim, B. J. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2010.03996.x · Cited by 52
Host antimicrobial proteins as endogenous immunomodulators
Hölzl, M. A., Hofer, J., Steinberger, P., Grabmeier‐Pfistershammer, K., & Zlabinger, G. J. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.05.003 · Cited by 57
HMGB1 and Microparticles as Mediators of the Immune Response to Cell Death
Pisetsky, D. S., Gauley, J., & Ullal, A. J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3865 · Cited by 50
“The stimulation of cells by DNA is likely potentiated by molecules such as HMGB1 and LL37 which bind DNA to form immunostimulatory complexes (36).”
BackgroundLL-37 Peptide Enhancement of Signal Transduction by Toll-like Receptor 3 Is Regulated by pH
Singh, D., Vaughan, R. C., & Kao, C. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582973 · Cited by 55
“Elevated levels of LL-37 are associated with the inflammatory response to self-DNA by TLR9 (34) and to viral dsRNAs that are the agonists for TLR3 (10, 11).”
BackgroundJukkola‐Vuorinen, A., Rahko, E. K., Vuopala, K. S., Desmond, R. A., Lehenkari, P. P., Harris, K. W., & Selander, K. S. (2008) · Journal of Innate Immunity · doi:10.1159/000151602 · Cited by 50
Coorens, M., van Dijk, A. I. J. M., Bikker, F. J., Veldhuizen, E. J. A., & Haagsman, H. P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501242 · Cited by 51
“The ability of LL-37 to enhance DNA-induced activation in pDCs is dependent on complex formation between LL-37 and DNA (18).”
InfluentialDiscrimination Between Self and Non-Self-Nucleic Acids by the Innate Immune System
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.08.004 · Cited by 49
“The LL37-DNA complex is then translocated into the endocytic compartments of pDCs, inducing TLR9 activation and resulting in a sustained type I IFN response (Lande et al., 2007 (Lande et al., , 2011 .”
At the crossroads of gout and psoriatic arthritis: “psout”
Felten, R., Duret, P., Gottenberg, J., Spielmann, L., & Messer, L. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-04981-0 · Cited by 57
Santa, P., Garreau, A., Serpas, L., Ferrière, A., Blanco, P., Soni, C., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629922 · Cited by 71
“In addition to gDNA, NETs are composed of mtDNA, and both can be associated with the anti-microbial peptide LL37 (48) which protects such DNA from degradation (49).”
BackgroundLi, H.-N., Barlow, P. G., Bylund, J., Mackellar, A., Björstad, Å., Conlon, J., Hiemstra, P. S., Haslett, C., Gray, M., Simpson, A. J., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209050 · Cited by 49
“In addition, LL-37 has been proposed recently to contribute to the pathogenesis of psoriasis [35], and the concentration of hCAP-18/LL-37 was reported to be 1.”
Background
Metadata
- Authors
- Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schröder, J.-M., Liu, Y.-J., & Gilliet, M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Genentech (US)
- Heinrich Heine University Düsseldorf (DE)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Gilliet, Michel
- ORCID
- Venue
- Nature
- Published
- 2007-09-16
- Volume
- 449
- Issue
- 7162
- Pages
- 564-569
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2084951281
- Cited by
- 1,910
- References
- 43
- Citations by year
- 2026: 54 · 2025: 61 · 2024: 87 · 2023: 81 · 2022: 94 · 2021: 93 · 2020: 89 · 2019: 97 · 2018: 92 · 2017: 118 · 2016: 105 · 2015: 81 · 2014: 113 · 2013: 120 · 2012: 181
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI074809)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- plasmacytoid dendritic cells, LL-37, antimicrobial peptides, self-DNA, TLR9, type I interferon, psoriasis, autoimmunity, innate immune tolerance, vaccine adjuvants, skin inflammation
- MeSH terms
- Autoantigens, Autoimmune Diseases, Dendritic Cells, DNA, Endocytosis, Humans, Psoriasis, Endosomes, Autoimmunity, Antimicrobial Cationic Peptides, Toll-Like Receptor 9, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.